- €1.07bn
- €899.19m
- €1.05bn
- 73
- 51
- 17
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,083 | 770 | 804 | 1,058 | 1,050 |
Cost of Revenue | |||||
Gross Profit | 429 | 284 | 287 | 413 | 439 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 973 | 774 | 791 | 971 | 959 |
Operating Profit | 110 | -4.33 | 13 | 87.6 | 91.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 116 | -4.45 | 11.8 | 88.5 | 96 |
Provision for Income Taxes | |||||
Net Income After Taxes | 95 | -4.45 | 9.71 | 72.6 | 78.7 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 95.4 | -4.39 | 8.88 | 75.2 | 80.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 95.4 | -4.39 | 8.88 | 75.2 | 80.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.06 | 0.154 | 0.142 | 0.839 | 0.935 |
Dividends per Share |